Lipitor

DRUG7 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Milton S. Hershey Medical Center, Johns Hopkins University, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Hormozgan University of Medical Sciences

Conditions

Chronic Kidney DiseaseDiabetesEnd-Stage Renal DiseaseHypercholesterolemiaPolycystic Ovary Syndrome

Phase 1

Bioequivalence Study On Pediatric Appropriate Formulation

CompletedNCT00777517

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Hypercholesterolemia

Start: 2008-11-30End: 2009-02-28Updated: 2021-02-18

Phase 2

A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

CompletedNCT00529542

Milton S. Hershey Medical CenterPolycystic Ovary Syndrome

Start: 2004-12-31End: 2010-08-31Updated: 2014-09-25

Phase 3

Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia

CompletedNCT01710007

Orient Pharma Co., Ltd.Hypercholesterolemia

Start: 2011-11-30End: 2012-11-30Updated: 2023-07-17

Phase 4

Bioavailability Study for New Atorvastatin Formulation

CompletedNCT00844376

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Hypercholesterolemia

Start: 2008-02-29End: 2008-03-31Updated: 2021-03-10

Unknown Phase

Pediatric Kidney Transplant Without Calcineurin Inhibitors

CompletedNCT00023231

National Institute of Allergy and Infectious Diseases (NIAID)End-Stage Renal Disease

Start: 2001-02-28End: 2006-08-31Updated: 2016-10-21

Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging

TerminatedNCT00770679

Johns Hopkins UniversityDiabetes

Start: 2008-06-30End: 2012-07-31Updated: 2017-09-13

Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients

CompletedNCT01305317

Hormozgan University of Medical SciencesChronic Kidney Disease

Start: 2007-01-31End: 2010-01-31Updated: 2011-03-01